CN1184978C - Chinese medicine for treating diabetes and keto acid toxication - Google Patents
Chinese medicine for treating diabetes and keto acid toxication Download PDFInfo
- Publication number
- CN1184978C CN1184978C CNB001231189A CN00123118A CN1184978C CN 1184978 C CN1184978 C CN 1184978C CN B001231189 A CNB001231189 A CN B001231189A CN 00123118 A CN00123118 A CN 00123118A CN 1184978 C CN1184978 C CN 1184978C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- traditional chinese
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a traditional Chinese medicine for treating diabetic complicated ketoacidosis, which is prepared from 25 kinds of traditional Chinese medicines, such as yam, astragalus root, rehmannia root, kakuda figwort root, Chinese angelica root, gardenia, atractylodes rhizome, scutellaria root, etc. A preparation method of the traditional Chinese medicine comprises the following steps: firstly, all medicines are respectively dried, sterilized and pulverized and then are uniformly mixed together to be sterilized again, and the traditional Chinese medicine of the present invention can be obtained. The present invention has the advantages of benefiting vital energy and nourishing blood, regulating metabolic balance and reducing ketone bodies. Clinics verify that ordinary urine acetone body plus signs between 1 and 2 can be eliminated after the traditional Chinese medicine is taken for 10 to 30 days, and the effectual rate is above 70%.
Description
Technical field:
The present invention relates to the treatment Drug of diabetic complication.Definite a kind of Chinese medicine that diabetes merge ketoacidosis for the treatment of of saying so.
Technical background:
Diabetes patient Chang Bingfa ketoacidosis is meant in the diabetes evolution, because acid metabolic product in the body, ketoboidies produces too much, overruns, surpass tissue and utilize limit, cause blood ketone to raise, urine ketone occurs, show as exaggerated respiration, quickening, be big breathing, often with asthenia.Feel sick, symptom such as vomiting, and can cause a kind of serious acute intercurrent disease of diabetes of stupor.Stupor person generally based on insulin, takes place then based on rescue in primary disease in treatment.Slow for disease progression, the state of an illness is relatively stable, the patient that poisoning symptom is not serious should adopt with the disease evolution, takes very inconveniently, and does very system not of observation of curative effect.
Summary of the invention:
The purpose of this invention is to provide the diabetes complicated handle of a kind of treatment and demonstrate,prove acidosic Chinese medicine preparation, its function is: strengthening the body resistance, and the cleaning detoxifcation is nourished blood and blood, and post-equalization is cloudy, the ketoboidies that disappears, reaching is the effect that blood sugar lowering is treated diabetes complicated ketosis poisoning again.
Medicine of the present invention is a raw material with Rhizoma Dioscoreae, the Radix Astragali, the Radix Rehmanniae, Radix Scrophulariae, Radix Angelicae Sinensis, Fructus Gardeniae, Rhizoma Atractylodis, Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Herba Euphorbiae Helioscopiae (Rhizoma Alismatis), Poria, pollen, wherein Rhizoma Dioscoreae, the Radix Astragali, the Radix Rehmanniae are monarch drug, Radix Scrophulariae, Radix Angelicae Sinensis, Fructus Gardeniae are ministerial drug, and assistant is with Rhizoma Atractylodis, Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Rhizoma Alismatis, Poria and pollen.
Each raw material weight number ratio of medicine of the present invention is:
Rhizoma Dioscoreae 50-70 Radix Astragali 30-50 Radix Scrophulariae 25-45
Radix Rehmanniae 20-40 Fructus Gardeniae 10-30 Radix Angelicae Sinensis 10-30
Rhizoma Atractylodis 10-30 Radix Scutellariae 5-20 Rhizoma Coptidis 5-20
Cortex Phellodendri 5-20 Radix Paeoniae Rubra 5-20 Rhizoma Chuanxiong 5-20
Herba Euphorbiae Helioscopiae (Rhizoma Alismatis) 5-20 Poria 5-20 pollen 5-20
The method that above-mentioned each raw material is made medicine is: the Fructus Gardeniae after will screening, Rhizoma Dioscoreae, the Radix Rehmanniae, the Radix Astragali, Radix Scrophulariae, Radix Angelicae Sinensis, Rhizoma Atractylodis, Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Herba Euphorbiae Helioscopiae (Rhizoma Alismatis), Poria, pollen are selected respectively, pulverize behind the rinsing after drying, ultraviolet disinfection, the medicine mixing is sterilized again packing patent medicine.
Good effect of the present invention is: Rhizoma Dioscoreae, the Radix Astragali, the Radix Rehmanniae nourish blood and blood, post-equalization is cloudy, the ketoboidies effect disappears, after above-mentioned each medicine combination, evident in efficacy to diabetic ketoacidosis, have no side effect, add the blood sugar lowering ketone capsule that disappears through clinical employing Jiangtang capsule and be used, benefiting QI and nourishing blood is arranged, regulate metabolic balance, the ketoboidies that disappears, pull gas the moon, ketoboidies is descended.Through clinical verification, generally urinate to take between the ketoboidies plus sige 1-2 and can eliminate in ten to 30 days, as 3 generally need to obey more than the plus sige 30 to 45 arrive about.Effect is satisfied.Obvious effective rate is more than 70%.
Embodiment 1: after the Rhizoma Dioscoreae 50g after at first will screening, Radix Astragali 30g, Radix Scrophulariae 25g, Radix Rehmanniae 20g, Fructus Gardeniae 10g, Radix Angelicae Sinensis 10g, Rhizoma Atractylodis 10g, Radix Scutellariae 5g, Rhizoma Coptidis 5g, Cortex Phellodendri 5g, Radix Paeoniae Rubra 5g, Rhizoma Chuanxiong 5g, Herba Euphorbiae Helioscopiae (Rhizoma Alismatis) 5g, Poria 5g, pollen 5g select respectively and carry out rinsing, drying, ultraviolet disinfection, pulverizing is 100 orders-200 an order medicated powder, the sterilization again behind the mixing of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Embodiment 2: after the Rhizoma Dioscoreae 70g after at first will screening, Radix Astragali 50g, Radix Scrophulariae 45g, Radix Rehmanniae 40g, Fructus Gardeniae 30g, Radix Angelicae Sinensis 30g, Rhizoma Atractylodis 30g, Radix Scutellariae 20g, Rhizoma Coptidis 20g, Cortex Phellodendri 20g, Radix Paeoniae Rubra 20g, Rhizoma Chuanxiong 20g, Herba Euphorbiae Helioscopiae (Rhizoma Alismatis) 20g, Poria 20g, pollen 20g carry out rinsing drying, ultraviolet disinfection respectively, pulverizing is 100 orders-120 an order medicated powder, the sterilization again behind the mixing of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Embodiment 3: be preparation optimum weight umber originally: after the Rhizoma Dioscoreae 60g after at first will screening, Radix Astragali 40g, Radix Scrophulariae 35g, Radix Rehmanniae 30g, Fructus Gardeniae 20g, Radix Angelicae Sinensis 20g, Rhizoma Atractylodis 20g, Radix Scutellariae 15g, Rhizoma Coptidis 15g, Cortex Phellodendri 15g, Radix Paeoniae Rubra 15g, Rhizoma Chuanxiong 15g, Herba Euphorbiae Helioscopiae (Rhizoma Alismatis) 15g, Poria 15g, pollen 15g carry out rinsing, drying, ultraviolet disinfection respectively, pulverizing is 100 orders-120 an order medicated powder, the sterilization again behind the mixing of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Claims (2)
1, a kind of Chinese medicine for the treatment of diabetes complicated ketoacidosis, Ji Tezheng are that the raw material and the raw materials in part by weight ratio of this medicine is: Rhizoma Dioscoreae 50-70, Radix Astragali 30-50, Radix Scrophulariae 25-45, Radix Rehmanniae 20-40, Fructus Gardeniae 10-30, Radix Angelicae Sinensis 10-30, Rhizoma Atractylodis 10-30, Radix Scutellariae 5-20, Rhizoma Coptidis 5-20, Cortex Phellodendri 5-10, Radix Paeoniae Rubra 5-20, Rhizoma Chuanxiong 5-20, Rhizoma Alismatis 5-20, Poria 5-20, pollen 5-20.
2, a kind of manufacture method for the treatment of the Chinese medicine of diabetes complicated ketoacidosis as claimed in claim 1, it is characterized in that: the Rhizoma Dioscoreae after must selecting, the Radix Astragali, Radix Scrophulariae, the Radix Rehmanniae, Fructus Gardeniae, Radix Angelicae Sinensis, Rhizoma Atractylodis, Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Rhizoma Alismatis, Poria, pollen selects respectively, carry out rinsing, drying, ultraviolet disinfection after, pulverizing is 100 orders-120 an order medicated powder, the sterilization again behind the mixing of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001231189A CN1184978C (en) | 2000-10-20 | 2000-10-20 | Chinese medicine for treating diabetes and keto acid toxication |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001231189A CN1184978C (en) | 2000-10-20 | 2000-10-20 | Chinese medicine for treating diabetes and keto acid toxication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1349805A CN1349805A (en) | 2002-05-22 |
| CN1184978C true CN1184978C (en) | 2005-01-19 |
Family
ID=4589595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001231189A Expired - Fee Related CN1184978C (en) | 2000-10-20 | 2000-10-20 | Chinese medicine for treating diabetes and keto acid toxication |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1184978C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017253109B2 (en) * | 2016-04-19 | 2023-03-23 | Axcess Global Sciences, Llc | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101229269B (en) * | 2007-12-05 | 2010-11-03 | 邓德刚 | Blood-sugar reducing Chinese traditional medicine preparation capsule for treating diabetes |
-
2000
- 2000-10-20 CN CNB001231189A patent/CN1184978C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017253109B2 (en) * | 2016-04-19 | 2023-03-23 | Axcess Global Sciences, Llc | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1349805A (en) | 2002-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100496586C (en) | Medicinal liquor for treating hyperosteogency and koilorrhachic | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN1457818A (en) | Poison expelling and astheniz resisting balance pill and its preparing method | |
| CN1166394C (en) | Chinese medicine for treating pharyngitis and globus hystericus and its prepn | |
| CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN101708302A (en) | Chinese medicinal preparation for treating diabetes and preparation method thereof | |
| CN1131053C (en) | Chinese medicine for treating diabetes | |
| CN1245707A (en) | Chinese medicine for curing AIDS and carcinomatosis | |
| CN1057448C (en) | Method for prepn. of medicinal introducing bag for treating diabetes mellitus | |
| CN101130050A (en) | Traditional Chinese medicine for treating cold-dampness gastralgia | |
| CN100396320C (en) | Oral liquid and capsules of Chinese medicine for diabete by supplementing Qi and nourishing Yin and promotnig production of body fluid and quenching thirst | |
| CN1184978C (en) | Chinese medicine for treating diabetes and keto acid toxication | |
| CN101284084A (en) | Externally used Chinese medicine for curing hyperosteogeny and protrusion of lumbar intervertebral discs | |
| CN1255358A (en) | Chinese medicine for treating diabetes | |
| CN1320914C (en) | Menstruation regulating powder | |
| CN102670892A (en) | Medicament for treating infantile diarrhea | |
| CN1336212A (en) | Diabetes treating medicine | |
| CN105535779A (en) | Chinese medicinal composition for treating uremia | |
| CN1063066C (en) | Chinese medicine for treatment of gout | |
| CN1062176C (en) | Oral liquid for curing cancer | |
| CN1290553A (en) | Capsule for tonifying kidney | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN1054767C (en) | Pharmaceutical preparation for treatment of leukoderma | |
| CN100415270C (en) | Diabetes treating medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |